CMS: Drug Inflation Rebates Based On Price Hikes In Commercial, Medicare Markets

By John Wilkerson / October 6, 2022 at 5:56 PM

CMS officials said Thursday (Oct. 6) that Medicare drug inflation rebates are calculated on price hikes in both the commercial and Medicare markets, confusing lobbyists who thought that measure was stripped during the budget resolution process.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.